Bayer announced today the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park at the heart of China's largest biopharma cluster, Zhangjiang, Shanghai. Bayer Co.Lab is part of the global network of life science incubators situated in key innovation hubs, including Cambridge (USA), Kobe (Japan), and Berlin (Germany). The establishment of Bayer Co.Lab Shanghai represents a major milestone in Bayer's external innovation strategy, aimed at fostering open collaboration within the biotechnology ecosystem.
Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network
Bayer announced today the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park at the heart of China's largest biopharma cluster, Zhangjiang, Shanghai. Bayer Co.Lab is part of the global network of life science incubators situated in key innovation hubs, including Cambridge (USA), Kobe (Japan), and Berlin (Germany). The establishment of Bayer Co.Lab Shanghai represents a major milestone in Bayer's external innovation strategy, aimed at fostering open collaboration within the biotechnology ecosystem.
